Compounds > cyclopropane
Page last updated: 2024-09-20

cyclopropane

Description

cyclopropane : A cycloalkane composed of three carbon atoms to form a ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6351
CHEMBL ID1796999
CHEBI ID30365
MeSH IDM0097155

Synonyms (43)

Synonym
cyclopropan
cyclopropane
CHEBI:30365 ,
zyklopropan
75-19-4
ciclopropano
trimethylene
cyclopropanum
cyclopropane (usp/inn)
D03627
rc 270
hsdb 812
trimethylene (cyclic)
ciclopropano [inn-spanish]
cyclopropane [inn]
cyclopropane [anaesthetics, volatile]
einecs 200-847-8
cyclopropanum [inn-latin]
un1027
inchi=1/c3h6/c1-2-3-1/h1-3h
cyclopropane, >=99%
CHEMBL1796999
unii-99tb643425
99tb643425 ,
cyclopropane [un1027] [flammable gas]
cyclopropane [usp:inn]
AKOS015915611
cyclopropane [who-dd]
cyclopropane [hsdb]
cyclopropane [mi]
cyclopropane [usp impurity]
cyclopropane [mart.]
DTXSID4058786 ,
cyclopropnane
un 1027
DB13984
mfcd00001268
Q80250
cyclopropane, (liquefied)
cyclopropane, liquefied
dtxcid1047734
cyclopropane (usp impurity)
cyclopropane (mart.)

Research Excerpts

Overview

ExcerptReference
"Cyclopropane rings are an important structural motif frequently found in many natural products and pharmaceuticals. "( Kunzendorf, A; Poelarends, GJ; Saifuddin, M; Saravanan, T; Xu, G, 2021)
"Cyclopropane is a sweet-smelling, irritating gas."( Krause, JG; McCarthy, WB, 1989)

Roles (1)

RoleDescription
inhalation anaestheticnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cycloalkaneSaturated monocyclic hydrocarbons (with or without side chains).
cyclopropanesCyclopropane and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID603952In-vitro blood to lung partition coefficients of the compound, logP(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID603950In-vitro air to lung partition coefficients of the compound, logK(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID603951In-vitro air to blood partition coefficients of the compound, logK(blood) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (803)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990378 (47.07)18.7374
1990's25 (3.11)18.2507
2000's146 (18.18)29.6817
2010's212 (26.40)24.3611
2020's42 (5.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.11%)5.53%
Reviews25 (2.74%)6.00%
Case Studies4 (0.44%)4.05%
Observational0 (0.00%)0.25%
Other881 (96.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy: A Randomized Controlled Trial[NCT04658784]72 participants (Actual)Interventional2020-08-14Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Patients With Early Anatomic Recurrence

To evaluate anatomical failure of posterior compartment using a standard definition of anatomical cure will be defined as Ba or Bp at NCT04658784)
Timeframe: Week 6

InterventionParticipants (Count of Participants)
Intervention0
Control0

Suture Burden

To evaluate amount of suture burden present at time of surgery in posterior by compartment by measuring total amount of delayed absorbable suture used for posterior colporrhaphy in centimeters. (NCT04658784)
Timeframe: At time of surgery (Intraoperative)

Interventioncentimeters (Median)
Intervention10.5
Control26.9

American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) 30-day Postoperative Complications.

To evaluate differences in adverse outcomes, using number of adverse events (AEs) as defined by the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) 30-day postoperative complications criteria. These criteria were reviewed at the week 6 data collection time interval. (NCT04658784)
Timeframe: 30 days

,
InterventionAdverse events (Number)
Urinary tract infection (UTI)Surgical site infection (SSI)ReadmissionReturn to the operating room (OR)Unplanned reintubation
Control31001
Intervention50110

Change in Bowel Function Scores

To evaluate change in bowel function using the Pelvic Floor Distress Inventory- 20 (PFDI-20) sub-scale Colorectal-Anal Distress Inventory-8 (CRADI-8). Total score (range 0 to 100) with the higher the score the more distress. (NCT04658784)
Timeframe: Baseline, Week 6, and month 6

,
Interventionscore on a scale (Mean)
baseline6 weeksChange from baseline to 6 weeks6 monthsChange from baseline to 6 months
Control36.618.1-18.69.6-27.9
Intervention36.418.1-18.212.3-24.1

Change in Pelvic Organ Prolapse Symptoms

To evaluate change in pelvic organ prolapse symptoms using the Pelvic Floor Distress Inventory- 20 (PFDI-20) sub-scale the Pelvic Organ Prolapse Distress Inventory- 6 (POPDI-6). Total score (range 0 to 100) with the higher the score the more distress. (NCT04658784)
Timeframe: Baseline, Week 6, and Month 6

,
Interventionscore on a scale (Mean)
baseline6 weekschange from baseline to 6 weeks6 monthsChange from baseline to 6 months
Control52.111.2-40.98.3-43.1
Intervention53.413.8-39.67.2-46.7

Change in Postoperative Sexual Function Scores

To evaluate postoperative sexual function using the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire (PISQ-12). Total score (range 0 to 48) with a lower score associated with poorer/worse sexual function. (NCT04658784)
Timeframe: Month 6

,
Interventionscore on a scale (Mean)
Baseline6 monthsChange from baseline to 6 months
Control26.931.74.6
Intervention28.133.13.9

Number of Patients With Subjective Failure

"To evaluate subjective failure of posterior compartment using a negative response on POPDI-6 portion of the PFDI-20 questionnaire to questions: Do you usually have a sensation of bulging or protrusion from the vaginal area? and Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?" (NCT04658784)
Timeframe: Week 6 and Month 6

,
InterventionParticipants (Count of Participants)
6 weeks6 months
Control02
Intervention01

Operative Time

To evaluate operative time for posterior repair in minutes. (NCT04658784)
Timeframe: Time of Surgery

,
InterventionMinutes (Median)
Total procedure surgical timePosterior repair surgical time
Control16820.5
Intervention14621

Surgery Specific Adverse Events (AEs) Measured at 6-months.

To evaluate differences in adverse outcomes, using number of surgery specific adverse events. (NCT04658784)
Timeframe: month 6

,
InterventionAdverse events (Number)
de novo dyspareunianew or worsening pelvic pain >3monthsNew or worsening constipation > 3 monthsNew fecal incontinenceNerve injuryOtherClassified as Severe Adverse Event (SAE)
Control5411001
Intervention4121111

SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
acetone[no description available]medium50ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
benzene[no description available]medium30aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
carbon monoxide[no description available]medium70carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
salicylic acid[no description available]medium20monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
hydroquinone[no description available]medium10benzenediol;
hydroquinones		antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
methanol[no description available]medium30alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
nitrous oxide[no description available]medium670gas molecular entity;
nitrogen oxide		analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
1-propanol[no description available]medium10propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent
toluene[no description available]medium10methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
phenytoin[no description available]medium20imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
acebutolol[no description available]medium10aromatic amide;
ethanolamines;
ether;
monocarboxylic acid amide;
propanolamine;
secondary amino compound		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympathomimetic agent
alprazolam[no description available]medium10organochlorine compound;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
theophylline[no description available]medium10dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
atenolol[no description available]medium10ethanolamines;
monocarboxylic acid amide;
propanolamine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
barbital[no description available]medium60barbituratesdrug allergen
betaxolol[no description available]medium10propanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
biperiden[no description available]medium10piperidines;
tertiary alcohol;
tertiary amino compound		antidote to sarin poisoning;
antidyskinesia agent;
antiparkinson drug;
muscarinic antagonist;
parasympatholytic
bisoprolol[no description available]medium10secondary alcohol;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
verapamil[no description available]medium10aromatic ether;
nitrile;
polyether;
tertiary amino compound
chlorpromazine[no description available]medium40organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
clomipramine[no description available]medium10dibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
clotiazepam[no description available]medium10organic molecular entity
diazepam[no description available]medium101,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
valproic acid[no description available]medium10branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
enflurane[no description available]medium50ether;
organochlorine compound;
organofluorine compound		anaesthetic
ethenzamide[no description available]medium10organic molecular entity
ether[no description available]medium900ether;
volatile organic compound		inhalation anaesthetic;
non-polar solvent;
refrigerant
fentanyl[no description available]medium10anilide;
monocarboxylic acid amide;
piperidines		adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
fluoxetine[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
haloperidol[no description available]medium20aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
halothane[no description available]medium880haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
halothane[no description available]medium881haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
hexobarbital[no description available]medium20barbiturates
hydroxyzine[no description available]medium20hydroxyether;
monochlorobenzenes;
N-alkylpiperazine		anticoronaviral agent;
antipruritic drug;
anxiolytic drug;
dermatologic drug;
H1-receptor antagonist
lidocaine[no description available]medium50benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
imipramine[no description available]medium50dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
isoflurane[no description available]medium50organofluorine compoundinhalation anaesthetic
2-propanol[no description available]medium10secondary alcohol;
secondary fatty alcohol		protic solvent
lorazepam[no description available]medium10benzodiazepine
methoxyflurane[no description available]medium180ether;
organochlorine compound;
organofluorine compound		hepatotoxic agent;
inhalation anaesthetic;
nephrotoxic agent;
non-narcotic analgesic
methylphenidate[no description available]medium10beta-amino acid ester;
methyl ester;
piperidines
metoprolol[no description available]medium10aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
midazolam[no description available]medium10imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
nalidixic acid[no description available]medium101,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
nitrazepam[no description available]medium101,4-benzodiazepinone;
C-nitro compound		anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
oxprenolol[no description available]medium10aromatic ether
phenobarbital[no description available]medium10barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
pindolol[no description available]medium10indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
practolol[no description available]medium10acetamides;
ethanolamines;
propanolamine;
secondary alcohol;
secondary amino compound		anti-arrhythmia drug;
beta-adrenergic antagonist
propranolol[no description available]medium10naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
sevoflurane[no description available]medium10ether;
organofluorine compound		central nervous system depressant;
inhalation anaesthetic;
platelet aggregation inhibitor
tegafur[no description available]medium10organohalogen compound;
pyrimidines
thioridazine[no description available]medium10phenothiazines;
piperidines		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
tolbutamide[no description available]medium10N-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
trifluoperazine[no description available]medium170N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
trihexyphenidyl[no description available]medium10amine
chloroform[no description available]medium280chloromethanes;
one-carbon compound		carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
1,1,1-trichloroethane[no description available]medium10chloroethanespolar solvent
ethane[no description available]medium90alkane;
gas molecular entity		plant metabolite;
refrigerant
ethylene[no description available]medium160alkene;
gas molecular entity		plant hormone;
refrigerant
acetylene[no description available]medium40alkyne;
gas molecular entity;
terminal acetylenic compound
methylene chloride[no description available]medium10chloromethanes;
volatile organic compound		carcinogenic agent;
polar aprotic solvent;
refrigerant
ethylene oxide[no description available]medium90gas molecular entity;
oxacycle;
saturated organic heteromonocyclic parent		allergen;
mouse metabolite;
mutagen
1,1,1-trifluoro-2-chloroethane[no description available]medium10organofluorine compound
phencyclidine[no description available]medium10benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
butobarbital[no description available]medium10barbiturates
isobutyl alcohol[no description available]medium10alkyl alcohol;
primary alcohol		Saccharomyces cerevisiae metabolite
methylethyl ketone[no description available]medium10butanone;
dialkyl ketone;
methyl ketone;
volatile organic compound		bacterial metabolite;
polar aprotic solvent
trichloroethylene[no description available]medium260chloroethenesinhalation anaesthetic;
mouse metabolite
acrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acidmetabolite
penicillin v[no description available]medium10penicillin allergen;
penicillin
2-xylene[no description available]medium10xylene
3-methylpentane[no description available]medium10alkane;
volatile organic compound		allelochemical;
human metabolite;
non-polar solvent
methylcyclopentane[no description available]medium10cycloalkane;
volatile organic compound		human metabolite;
plant metabolite
4-chloro-alpha,alpha,alpha-trifluorotoluene[no description available]medium10
1,3-butadiene[no description available]medium30butadienecarcinogenic agent;
mutagen
2-methylpentane[no description available]medium30alkane
pentane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
refrigerant
n-hexane[no description available]medium10alkane;
volatile organic compound		neurotoxin;
non-polar solvent
cyclohexane[no description available]medium40cycloalkane;
volatile organic compound		non-polar solvent
propylene[no description available]medium20alkene;
gas molecular entity		refrigerant;
xenobiotic
n-heptane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
plant metabolite
glycyrrhetinic acid[no description available]medium10cyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		immunomodulator;
plant metabolite
erythromycin[no description available]medium10cyclic ketone;
erythromycin
sulfur hexafluoride[no description available]medium50sulfur coordination entitygreenhouse gas;
NMR chemical shift reference compound;
ultrasound contrast agent
toliprolol[no description available]medium10aromatic ether
dicloxacillin[no description available]medium10dichlorobenzene;
penicillin		antibacterial drug
helium[no description available]medium100monoatomic helium;
noble gas atom;
s-block element atom		food packaging gas
chloroprene[no description available]medium10chloroolefin
tetrachloroethylene[no description available]medium10chlorocarbon;
chloroethenes		nephrotoxic agent
pyrene[no description available]medium10ortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
cefazolin[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles		antibacterial drug
timolol[no description available]medium10timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
miloxacin[no description available]medium10quinolines
alfentanil[no description available]medium10monocarboxylic acid amide;
piperidines		central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
inaperisone[no description available]medium10aromatic ketone
4-phenylbenzoic acid[no description available]medium10
nicotine[no description available]medium203-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
cdri 81-470[no description available]medium10
yh 1885[no description available]medium10
quinidine[no description available]medium30cinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
cocaine[no description available]medium30benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
zithromax[no description available]medium10macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
cotinine[no description available]medium10N-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid		antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
terbinafine[no description available]medium10acetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
digoxin[no description available]medium10cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
thiopental[no description available]medium410barbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
pulmicort[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
sch 442416[no description available]medium10triazolopyrimidines
mobiflex[no description available]medium10heteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
olanzapine[no description available]medium10benzodiazepine;
N-arylpiperazine;
N-methylpiperazine		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
cytochrome c-t[no description available]medium20
belactosin a[no description available]medium40
hormaomycin[no description available]medium20
palladium[no description available]medium110metal allergen;
nickel group element atom;
platinum group metal atom
isocoumarins[no description available]medium20isocoumarins
2-oxindole[no description available]medium30gamma-lactam;
indolinone
indanidine[no description available]medium10
carbamates[no description available]medium20amino-acid anion
cyclopropene[no description available]medium60cycloalkene;
cyclopropenes
benzofurans[no description available]medium50
thiourea[no description available]medium10one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
bryostatin 1[no description available]medium10
methane[no description available]medium270alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
1,1-cyclopropanedicarboxylate[no description available]medium10
allyl alcohol[no description available]medium30primary allylic alcohol;
propenol		antibacterial agent;
fungicide;
herbicide;
insecticide;
plant metabolite
chlorine[no description available]medium40halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
bromide[no description available]medium90halide anion;
monoatomic bromine
uridine[no description available]medium20uridinesdrug metabolite;
fundamental metabolite;
human metabolite
propadiene[no description available]medium20allenes
chlamydocin[no description available]medium10
diazomethane[no description available]medium30diazo compoundalkylating agent;
antineoplastic agent;
carcinogenic agent;
poison
avibactam[no description available]medium10azabicycloalkane;
hydroxylamine O-sulfonic acid;
monocarboxylic acid amide;
ureas		antibacterial drug;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
diazabicyclo(2.2.2)octane[no description available]medium10
cyclic adp-ribose[no description available]medium10cyclic purine nucleotide;
nucleotide-sugar		metabolite;
ryanodine receptor agonist
inositol 1,4,5-trisphosphate[no description available]medium10myo-inositol trisphosphatemouse metabolite
styrene[no description available]medium50styrenes;
vinylarene;
volatile organic compound		mouse metabolite;
mutagen;
plant metabolite
alkenes[no description available]medium340
carbonates[no description available]medium40carbon oxoanion
furan[no description available]medium40furans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene		carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
colchicine[no description available]medium20alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
dimethyloxosulfonium methylide[no description available]medium20
bismuth[no description available]medium30metal atom;
pnictogen
rhodium[no description available]medium190cobalt group element atom
indoline[no description available]medium40indoles
epinephrine[no description available]medium10
carbene[no description available]medium180carbene;
methanediyl
phenylnitrene[no description available]medium10
s-adenosylmethionine[no description available]medium30organic cation;
sulfonium compound		coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
colibactin[no description available]medium401,3-thiazoles;
azaspiro compound;
polyketide;
pyrroline;
secondary carboxamide		alkylating agent;
carcinogenic agent;
Escherichia coli metabolite;
genotoxin
hydrogen carbonate[no description available]medium20carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
guaiane[no description available]medium10sesquiterpene;
terpenoid fundamental parent
sesquiterpenes[no description available]medium110
ambruticin[no description available]medium20
heme[no description available]medium10
cobalt[no description available]medium30cobalt group element atom;
metal allergen		micronutrient
warfarin[no description available]medium20benzenes;
hydroxycoumarin;
methyl ketone
coumarin[no description available]medium10coumarinsfluorescent dye;
human metabolite;
plant metabolite
1-methylcyclopropane[no description available]medium20
pyrethrins[no description available]medium20
fenvalerate[no description available]medium10aromatic ether;
carboxylic ester;
monochlorobenzenes		pyrethroid ester acaricide;
pyrethroid ester insecticide
ethofenprox[no description available]medium10aromatic etherpyrethroid ether insecticide
4-butyrolactone[no description available]medium40butan-4-olidemetabolite;
neurotoxin
butenolide[no description available]medium20butenolide
isocytosine[no description available]medium10aminopyrimidine;
pyrimidine nucleobase;
pyrimidone
cytosine[no description available]medium20aminopyrimidine;
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
ruthenium[no description available]medium60iron group element atom;
platinum group metal atom
(alpha-carboxycyclopropyl)glycine[no description available]medium10alpha-amino acid
gold[no description available]medium60copper group element atom;
elemental gold
beta-pinene[no description available]medium10pineneplant metabolite
1,2,3,4-tetrahydroquinoline[no description available]medium10quinolines
allylamine[no description available]medium10alkylamine
2,3-dihydrofuran[no description available]medium10dihydrofuran
gamma-aminobutyric acid[no description available]medium30amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
isoprene[no description available]medium10alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
7-epiclusianone[no description available]medium10
phenylacetylene[no description available]medium10benzenes
dicyanmethane[no description available]medium10aliphatic nitrile;
dinitrile
iodine[no description available]medium20diatomic iodinenutrient
oxazolidine[no description available]medium10oxazolidine
beta-lactams[no description available]medium20beta-lactam antibiotic allergen;
beta-lactam
oxazoles[no description available]medium501,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
procaine[no description available]medium60benzoate ester;
substituted aniline;
tertiary amino compound		central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
procainamide[no description available]medium30benzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
boranes[no description available]medium20boranes;
mononuclear parent hydride
boron trifluoride[no description available]medium10boron fluorideNMR chemical shift reference compound
vinyl iodide[no description available]medium10monohaloethene
sulfur[no description available]medium60chalcogen;
nonmetal atom		macronutrient
histidine[no description available]medium40amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
milnacipran[no description available]medium20acetamides
1,7-phenanthroline[no description available]medium10phenanthroline
epothilone a[no description available]medium20epothilone;
epoxide		antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
pipecolic acid[no description available]medium10piperidinemonocarboxylic acid
arginyl-glycyl-aspartic acid[no description available]medium20oligopeptide
trifluoromethanesulfonic acid[no description available]medium30one-carbon compound;
perfluoroalkanesulfonic acid
stilbenes[no description available]medium10stilbene
phosphine[no description available]medium10mononuclear parent hydride;
phosphanes;
phosphine		carcinogenic agent;
fumigant insecticide
iridium[no description available]medium10cobalt group element atom;
platinum group metal atom
hydrogen[no description available]medium80elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
indolizine[no description available]medium20indolizines;
mancude organic heterobicyclic parent
pyridine[no description available]medium60azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
pyrroles[no description available]medium110pyrrole;
secondary amine
phenol[no description available]medium40phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
dc 88-a[no description available]medium10
piperidines[no description available]medium40
phosphorus[no description available]medium70monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
piperidine[no description available]medium30azacycloalkane;
piperidines;
saturated organic heteromonocyclic parent;
secondary amine		base;
catalyst;
human metabolite;
non-polar solvent;
plant metabolite;
protic solvent;
reagent
antimycin[no description available]medium10
antimycin a[no description available]medium10amidobenzoic acid
cycloclavine[no description available]medium10
urea[no description available]medium50isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
nickel[no description available]medium40metal allergen;
nickel group element atom		epitope;
micronutrient
cyanates[no description available]medium10
glutamic acid[no description available]medium10glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
pyrrolidonecarboxylic acid[no description available]medium205-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
proline[no description available]medium10amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
oligonucleotides[no description available]medium30
brine[no description available]medium10
2,2,2-trifluorodiazoethane[no description available]medium10
thiophenes[no description available]medium10mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
iodine[no description available]medium10halide anion;
monoatomic iodine		human metabolite
benzoxazoles[no description available]medium101,3-benzoxazoles;
mancude organic heterobicyclic parent
cellulose[no description available]medium10glycoside
cupreine[no description available]medium10
phenylalanine[no description available]medium30amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
5-carboxytetramethylrhodamine succinimidyl ester[no description available]medium10
diethylzinc[no description available]medium10
methylene iodide[no description available]medium20
acrylonitrile[no description available]medium10aliphatic nitrile;
volatile organic compound		antifungal agent;
carcinogenic agent;
fungal metabolite;
mutagen;
polar aprotic solvent
galantamine[no description available]medium20benzazepine alkaloid fundamental parent;
benzazepine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound		antidote to curare poisoning;
cholinergic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant metabolite
thioctic acid[no description available]medium10dithiolanes;
heterocyclic fatty acid;
thia fatty acid		fundamental metabolite;
geroprotector
brevipolide h[no description available]medium10
platinum[no description available]medium10elemental platinum;
nickel group element atom;
platinum group metal atom
methacycline[no description available]medium101,2-diglyceride
ticagrelor[no description available]medium10aryl sulfide;
hydroxyether;
organofluorine compound;
secondary amino compound;
triazolopyrimidines		P2Y12 receptor antagonist;
platelet aggregation inhibitor
tranylcypromine[no description available]medium3002-phenylcyclopropan-1-amine
adenosine[no description available]medium30adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
tasimelteon[no description available]medium101-benzofurans;
cyclopropanes;
monocarboxylic acid amide		melatonin receptor agonist
mocetinostat[no description available]medium10aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
trimethylchlorosilane[no description available]medium10silyl chloridechromatographic reagent
cyclopropanecarboxamide[no description available]medium10cyclopropylcarboxamide
cyclopropanecarboxylic acid[no description available]medium20cyclopropanes;
monocarboxylic acid
butane[no description available]medium40alkane;
gas molecular entity		food propellant;
refrigerant
valine[no description available]medium30L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
tiletamine hydrochloride[no description available]medium40
silicon[no description available]medium10carbon group element atom;
metalloid atom;
nonmetal atom
acetic acid[no description available]medium10monocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
naltrexone[no description available]medium10cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound		antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
noroxymorphone[no description available]medium10phenanthrenes
morphinans[no description available]medium50isoquinoline alkaloid fundamental parent;
morphinane alkaloid
azides[no description available]medium10pseudohalide anionmitochondrial respiratory-chain inhibitor
phenyl acetate[no description available]medium40benzenes;
phenyl acetates
dibenzylchlorethamine[no description available]medium80
hydrofluoric acid[no description available]medium10hydrogen halide;
mononuclear parent hydride		NMR chemical shift reference compound
aziridine[no description available]medium50azacycloalkane;
aziridines;
saturated organic heteromonocyclic parent		alkylating agent
ytterbium(iii) triflate[no description available]medium10
cyclopentane[no description available]medium80cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
triflimide[no description available]medium10
vinyl ether[no description available]medium40ether
vinyl chloride[no description available]medium10chloroethenes;
gas molecular entity;
monohaloethene		carcinogenic agent
curacin a[no description available]medium10thiazoles
thiazoles[no description available]medium201,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
deoxyguanosine[no description available]medium20purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
tetrahydrofuran[no description available]medium10cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound		polar aprotic solvent
3-hydroxybutanal[no description available]medium20
diisopropylamine[no description available]medium10
praseodymium[no description available]medium10f-block element atom;
lanthanoid atom
farnesyl pyrophosphate[no description available]medium10farnesyl diphosphateEscherichia coli metabolite;
mouse metabolite
osmium tetroxide[no description available]medium10osmium coordination entityfixative;
histological dye;
oxidising agent;
poison
benzo(c)fluorene[no description available]medium10carbotetracyclic compound
3-azabicyclo(3.1.0)hexane[no description available]medium10
trifluoroethylamine[no description available]medium10
4-methylhistamine[no description available]medium10aralkylamino compound;
imidazoles		histamine agonist;
metabolite
alanine[no description available]medium20alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
benzofuran[no description available]medium101-benzofurans;
benzofuran
butyl chloride[no description available]medium10
aspidospermidine[no description available]medium10Aspidosperma alkaloid;
indole alkaloid fundamental parent
goniomitine[no description available]medium10monoterpenoid indole alkaloid
5-azaindole[no description available]medium10
azetidyl-2-carboxylic acid[no description available]medium10azetidine-2-carboxylic acid
azetidine[no description available]medium10azacycloalkane;
azetidines;
saturated organic heteromonocyclic parent
acrolein[no description available]medium10enalherbicide;
human xenobiotic metabolite;
toxin
ferric chloride[no description available]medium20iron coordination entityastringent;
Lewis acid
tempo[no description available]medium10aminoxyls;
piperidines		catalyst;
ferroptosis inhibitor;
radical scavenger
fructans[no description available]medium10
deoxyglucose[no description available]medium20
d-glucal[no description available]medium10
meperidine[no description available]medium170ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
mannose[no description available]medium30D-aldohexose;
D-mannose;
mannopyranose		metabolite
salvileucalin b[no description available]medium20bridged compound;
diterpenoid;
furans;
gamma-lactone		antineoplastic agent;
metabolite
epothilone b[no description available]medium10epothilone;
epoxide		antineoplastic agent;
apoptosis inducer;
microtubule-stabilising agent
dibenzylidene acetone[no description available]medium10
succinimide[no description available]medium10dicarboximide;
pyrrolidinone
cyclopropylcarbinol[no description available]medium10
quinone[no description available]medium201,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
fullerene c60[no description available]medium10fullerenegeroprotector
meloscine[no description available]medium10
diphthamide[no description available]medium10quaternary ammonium ion
wyosine[no description available]medium10carbamate ester;
methyl ester;
nucleoside analogue
squalene[no description available]medium10triterpenehuman metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
diploptene[no description available]medium10triterpene
dimethyl disulfide[no description available]medium10organic disulfidexenobiotic metabolite
indium[no description available]medium10boron group element atom
arginine[no description available]medium20arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
oxetane[no description available]medium10oxetanes;
saturated organic heteromonocyclic parent
sodium acetate, anhydrous[no description available]medium10organic sodium saltNMR chemical shift reference compound
sodium carbonate[no description available]medium10carbonate salt;
organic sodium salt
n,n'-dibutylurea[no description available]medium10
iodobenzene[no description available]medium10
1-palmitoyl-2-oleoylphosphatidylcholine[no description available]medium10
phosphatidylcholines[no description available]medium301,2-diacyl-sn-glycero-3-phosphocholine
1-palmitoyl-2-oleoylphosphatidylethanolamine[no description available]medium10(18R,21S)-24-amino-21-hydroxy-21-oxido-15-oxo-16,20,22-trioxa-21lambdalambda(5)-phosphatetracosan-18-yl icosanoate;
phosphatidylethanolamine
serine[no description available]medium10L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
threonine[no description available]medium10amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
glycosides[no description available]medium10
acylfulvene[no description available]medium10
barbituric acid[no description available]medium30barbituratesallergen;
xenobiotic
palladium chloride[no description available]medium10palladium coordination entitycatalyst
phenylacetic acid[no description available]medium10benzenes;
monocarboxylic acid;
phenylacetic acids		allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
fluorine[no description available]medium10diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
phosphonic acid[no description available]medium10
indole[no description available]medium10indole;
polycyclic heteroarene		Escherichia coli metabolite
clavosolide a[no description available]medium10
1,1,2,2-tetrachloroethane[no description available]medium10chloroethanes
kojic acid[no description available]medium104-pyranones;
enol;
primary alcohol		Aspergillus metabolite;
EC 1.10.3.1 (catechol oxidase) inhibitor;
EC 1.10.3.2 (laccase) inhibitor;
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor;
NF-kappaB inhibitor;
skin lightening agent
perezone[no description available]medium10
allylsilane[no description available]medium10
triazoles[no description available]medium101,2,3-triazole
methionine[no description available]medium40aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
leucine[no description available]medium10amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
colletoic acid[no description available]medium10
benzimidazole[no description available]medium10benzimidazole;
polycyclic heteroarene
strychnine[no description available]medium10monoterpenoid indole alkaloid;
organic heteroheptacyclic compound		avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
malondialdehyde[no description available]medium20dialdehydebiomarker
1,2-cyclohexanediol[no description available]medium10diol
cyclohexanol[no description available]medium10cyclohexanols;
secondary alcohol		solvent
benzenediazonium[no description available]medium10aromatic diazonium ionhapten
fr 900848[no description available]medium10cyclopropanes;
nucleoside analogue;
olefinic compound;
polyketide;
secondary carboxamide		antifungal agent;
bacterial metabolite
lysine[no description available]medium20aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
terephthalic acid[no description available]medium10benzenedicarboxylic acid
ethyl chloride[no description available]medium80chloroethanesantipruritic drug;
inhalation anaesthetic;
local anaesthetic
phenylephrine[no description available]medium30phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
neostigmine[no description available]medium20quaternary ammonium ionantidote to curare poisoning;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
atropine[no description available]medium190
oxytocin[no description available]medium70heterodetic cyclic peptide;
peptide hormone		oxytocic;
vasodilator agent
succinylcholine[no description available]medium230quaternary ammonium ion;
succinate ester		drug allergen;
muscle relaxant;
neuromuscular agent
mephentermine[no description available]medium10amphetamines
trimethaphan camsylate[no description available]medium10
trimethaphan[no description available]medium10sulfonium compoundanaesthesia adjuvant;
antihypertensive agent;
nicotinic antagonist;
vasodilator agent
morphine[no description available]medium90morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
isoquinoline[no description available]medium40azaarene;
isoquinolines;
mancude organic heterobicyclic parent;
ortho-fused heteroarene
tubocurarine[no description available]medium80bisbenzylisoquinoline alkaloiddrug allergen;
muscle relaxant;
nicotinic antagonist
trimedoxime bromide[no description available]medium40
pentobarbital[no description available]medium80barbituratesGABAA receptor agonist
phenothiazine[no description available]medium30phenothiazineferroptosis inhibitor;
plant metabolite;
radical scavenger
perphenazine[no description available]medium10N-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines		antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
reserpine[no description available]medium60alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
amphetamine[no description available]medium20primary amine
1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride[no description available]medium10
sarin[no description available]medium10fluorine molecular entity;
phosphinic ester
isoflurophate[no description available]medium20dialkyl phosphate
angiotensin amide[no description available]medium10oligopeptide
parstelin[no description available]medium20
pralidoxime[no description available]medium10pyridinium ionantidote to organophosphate poisoning;
antidote to sarin poisoning;
cholinergic drug;
cholinesterase reactivator
ammonium hydroxide[no description available]medium20azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
iproniazid[no description available]medium30carbohydrazide;
pyridines
hydrazine[no description available]medium20azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
scopolamine hydrobromide[no description available]medium90
dichloroisoproterenol[no description available]medium10
isoproterenol[no description available]medium30catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
acetaldehyde oxime[no description available]medium10acetaldehyde oxime
1-methylpyridinium[no description available]medium10methylpyridines
gallamine triethiodide[no description available]medium50
angiotensin a[no description available]medium10
tetracaine[no description available]medium20benzoate ester;
tertiary amino compound		local anaesthetic
krypton[no description available]medium40monoatomic krypton;
noble gas atom;
p-block element atom
adiphenine[no description available]medium10diarylmethane
copper gluconate[no description available]medium10organic molecular entity
triamcinolone[no description available]medium1011beta-hydroxy steroid;
16alpha-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
prednisolone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
betamethasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
hydrochlorothiazide[no description available]medium10benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
thiethylperazine[no description available]medium10N-methylpiperazine;
phenothiazines		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
pronethalol[no description available]medium20naphthalenes
cyclopropylamine[no description available]medium10primary aliphatic aminemouse metabolite
urethane[no description available]medium10carbamate esterfungal metabolite;
mutagen
hydroxydione[no description available]medium1020-oxo steroid;
21-hydroxy steroid;
3-oxo-5beta-steroid;
primary alpha-hydroxy ketone		human xenobiotic metabolite
promethazine[no description available]medium20phenothiazines;
tertiary amine		anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
xenon[no description available]medium70monoatomic xenon;
noble gas atom;
p-block element atom
methyl chloride[no description available]medium10chloromethanes;
methyl halides		marine metabolite;
mutagen;
refrigerant
argon[no description available]medium40monoatomic argon;
noble gas atom;
p-block element atom		food packaging gas;
neuroprotective agent
neon[no description available]medium10monoatomic neon;
noble gas atom;
p-block element atom
fluorides[no description available]medium20halide anion;
monoatomic fluorine
streptomycin[no description available]medium10antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
chloral hydrate[no description available]medium10aldehyde hydrate;
ethanediol;
organochlorine compound		general anaesthetic;
mouse metabolite;
sedative;
xenobiotic
sulfur dioxide[no description available]medium10sulfur oxideEscherichia coli metabolite;
food bleaching agent;
refrigerant
cyanides[no description available]medium20pseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor
tribromoethanol[no description available]medium30alcohol;
organobromine compound
secobarbital[no description available]medium10barbituratesanaesthesia adjuvant;
GABA modulator;
sedative
felypressin[no description available]medium30heterodetic cyclic peptidevasoconstrictor agent;
vasopressin receptor agonist
pituitrin[no description available]medium40
quinine[no description available]medium10cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
ephedrine[no description available]medium20phenethylamine alkaloid;
phenylethanolamines		bacterial metabolite;
environmental contaminant;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
carcainium chloride[no description available]medium10
ammonium chloride[no description available]medium10ammonium salt;
inorganic chloride		ferroptosis inhibitor
lypressin[no description available]medium10cyclic peptide
bilirubin[no description available]medium10biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
thymol[no description available]medium10monoterpenoid;
phenols		volatile oil component
phentolamine[no description available]medium20imidazoles;
phenols;
substituted aniline;
tertiary amino compound		alpha-adrenergic antagonist;
vasodilator agent
fluroxene[no description available]medium60organofluorine compound
palmitic acid[no description available]medium40long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
ornithine[no description available]medium10non-proteinogenic L-alpha-amino acid;
ornithine		algal metabolite;
hepatoprotective agent;
mouse metabolite
galactose[no description available]medium10
choline[no description available]medium20cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
potassium permanganate[no description available]medium10
stearic acid[no description available]medium10long-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
oleic acid[no description available]medium10octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
glycerol[no description available]medium10alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
ouabain[no description available]medium1011alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone		anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
chlorobutanol[no description available]medium10tertiary alcohol
halopropane[no description available]medium20organofluorine compound
propane[no description available]medium50alkane;
gas molecular entity		food propellant
methadone[no description available]medium10benzenes;
diarylmethane;
ketone;
tertiary amino compound
mannitol[no description available]medium30mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
pregnenolone[no description available]medium1020-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid		human metabolite;
mouse metabolite
methoxamine[no description available]medium20amphetaminesalpha-adrenergic agonist;
antihypotensive agent
urobilinogen[no description available]medium10bilaneshuman metabolite
nikethamide[no description available]medium10pyridinecarboxamide
indan[no description available]medium10indanes;
ortho-fused bicyclic hydrocarbon
homocysteine[no description available]medium10amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
s-adenosylhomocysteine[no description available]medium10adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide		cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
ozone[no description available]medium10elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
hydantoins[no description available]medium10imidazolidine-2,4-dione
ethionamide[no description available]medium10pyridines;
thiocarboxamide		antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
pyrazinamide[no description available]medium10monocarboxylic acid amide;
N-acylammonia;
pyrazines		antitubercular agent;
prodrug
cycloserine[no description available]medium104-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion		antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist
cyclohexanone[no description available]medium10cyclohexanoneshuman xenobiotic metabolite
diethylpropion[no description available]medium10aromatic ketone;
tertiary amine		appetite depressant
1,2-oleoylphosphatidylcholine[no description available]medium10phosphatidylcholine(1+)
nsc 614846[no description available]medium20carbovirHIV-1 reverse transcriptase inhibitor
guanosine[no description available]medium10guanosines;
purines D-ribonucleoside		fundamental metabolite
beta-aspartyl phosphate[no description available]medium10aminoacyl phosphate;
L-aspartic acid derivative;
non-proteinogenic L-alpha-amino acid		Escherichia coli metabolite
aspartic acid[no description available]medium10aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
tetrafluoromethane[no description available]medium10fluorocarbon;
fluoromethanes		refrigerant
ergonovine[no description available]medium10ergot alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound;
primary alcohol;
secondary amino compound;
tertiary amino compound		diagnostic agent;
fungal metabolite;
oxytocic;
toxin
duocarmycin sa[no description available]medium10
cc 1065[no description available]medium10
glycine[no description available]medium30alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
picrotoxin[no description available]medium10
methamphetamine[no description available]medium10amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
tyrosine[no description available]medium10amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
alpha-ketobutyric acid[no description available]medium102-oxo monocarboxylic acid;
short-chain fatty acid
beta-alanine[no description available]medium10amino acid zwitterion;
beta-amino acid		agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
pyridoxal phosphate[no description available]medium10methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
vinylglycine[no description available]medium10glycine derivative;
L-alpha-amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor
3-chloroalanine[no description available]medium10chloroalanine;
non-proteinogenic alpha-amino acid;
organochlorine compound
clodronic acid[no description available]medium101,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound		antineoplastic agent;
bone density conservation agent
glycolipids[no description available]medium10
organophosphonates[no description available]medium10divalent inorganic anion;
phosphite ion
difluoromethylene diphosphonate[no description available]medium10
2-amino-4-phosphonobutyric acid[no description available]medium10
cord factors[no description available]medium20
chrysanthemic acid[no description available]medium10cyclopropanes;
monocarboxylic acid		plant metabolite
diphenyl[no description available]medium10aromatic fungicide;
benzenes;
biphenyls		antifungal agrochemical;
antimicrobial food preservative
oleanolic acid[no description available]medium10hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite
betulinic acid[no description available]medium10hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
betulonic acid[no description available]medium10triterpenoidanticoronaviral agent
lignans[no description available]medium10
cyclopentenone[no description available]medium10alicyclic ketone;
enone		Hsp70 inducer
eglumetad[no description available]medium10L-alpha-amino acid
discodermolide[no description available]medium10
1-hexene[no description available]medium10alkene
diazoacetic ester[no description available]medium20
1-methylimidazole[no description available]medium10imidazoles
pyrrolidine[no description available]medium10azacycloalkane;
pyrrolidines;
saturated organic heteromonocyclic parent
hydroxylamine[no description available]medium10hydroxylaminesalgal metabolite;
bacterial xenobiotic metabolite;
EC 1.1.3.13 (alcohol oxidase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
nitric oxide donor;
nucleophilic reagent
cupric chloride[no description available]medium10copper molecular entity;
inorganic chloride		EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
indazoles[no description available]medium10indazole
chlorine[no description available]medium10diatomic chlorine;
gas molecular entity		bleaching agent
fulvene[no description available]medium10fulvenes
cyclopentanone[no description available]medium10cyclopentanonesMaillard reaction product
lithium[no description available]medium10alkali metal atom
lanthanum[no description available]medium10f-block element atom;
lanthanoid atom;
scandium group element atom
sodium iodide[no description available]medium10inorganic sodium salt;
iodide salt
cycloleucine[no description available]medium10non-proteinogenic alpha-amino acidEC 2.5.1.6 (methionine adenosyltransferase) inhibitor
chiniofon[no description available]medium10
thioacetazone[no description available]medium10
dihydroergocornine[no description available]medium10ergot alkaloid
dihydroergotamine[no description available]medium10ergot alkaloid;
semisynthetic derivative		dopamine agonist;
non-narcotic analgesic;
serotonergic agonist;
sympatholytic agent;
vasoconstrictor agent
acyclovir[no description available]medium102-aminopurines;
oxopurine		antimetabolite;
antiviral drug
valacyclovir[no description available]medium10L-valyl esterantiviral drug
ottelione a[no description available]medium10
cytisine[no description available]medium10alkaloid;
bridged compound;
lactam;
organic heterotricyclic compound;
secondary amino compound		nicotinic acetylcholine receptor agonist;
phytotoxin;
plant metabolite
pyrroline[no description available]medium10pyrroline
diazobenzenesulfonic acid[no description available]medium10
minfiensine[no description available]medium10
pestalotiopsin a[no description available]medium10
dezocine[no description available]medium10phenols;
primary amino compound		opioid analgesic
n-methylpyrrole[no description available]medium10pyrroles
stallimycin[no description available]medium10
histamine[no description available]medium10aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
sodium hydroxide[no description available]medium10alkali metal hydroxide
soda lime[no description available]medium10
diethylstilbestrol[no description available]medium10olefinic compound;
polyphenol		antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
nevirapine[no description available]medium10cyclopropanes;
dipyridodiazepine		antiviral drug;
HIV-1 reverse transcriptase inhibitor
1-aminocyclopropane-1-carboxylic acid[no description available]medium10amino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid		ethylene releasers;
plant metabolite
caprolactone[no description available]medium10epsilon-lactone
1-anilino-8-naphthalenesulfonate[no description available]medium10aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
paclitaxel[no description available]medium10taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
lactic acid[no description available]medium102-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
linoleic acid[no description available]medium10octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
acetonitrile[no description available]medium10aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
1,4-dioxane[no description available]medium10dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
azulene[no description available]medium10azulenes;
mancude carbobicyclic parent;
ortho-fused bicyclic arene		plant metabolite;
volatile oil component
limonene[no description available]medium10cycloalkene;
p-menthadiene		human metabolite
tellurium[no description available]medium10chalcogen;
metalloid atom
hempa[no description available]medium10phosphoramideinsect sterilant;
mutagen
isovelleral[no description available]medium10aldehyde
guanine[no description available]medium102-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
cyclohexene[no description available]medium10cycloalkene
pyrimidinones[no description available]medium10
rosaprostol[no description available]medium10prostanoid
nitrogenase[no description available]medium10
ketamine[no description available]medium10cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
desflurane[no description available]low00organofluorine compoundinhalation anaesthetic
methylcyclohexane[no description available]low00cycloalkane;
volatile organic compound		aprotic solvent;
human metabolite;
plant metabolite
ethylcyclohexane[no description available]low00cycloalkane
ciprofibrate[no description available]low00cyclopropanes;
monocarboxylic acid;
organochlorine compound		antilipemic drug
ciprofloxacin[no description available]low00aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
2-phenylcyclopropan-1-amine[no description available]low00benzenes;
cyclopropanes;
primary amine
permethrin[no description available]low00cyclopropanecarboxylate ester;
cyclopropanes		agrochemical;
ectoparasiticide;
pyrethroid ester acaricide;
pyrethroid ester insecticide;
scabicide
efavirenz[no description available]low00acetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound		antiviral drug;
HIV-1 reverse transcriptase inhibitor
enrofloxacin[no description available]low00cyclopropanes;
N-alkylpiperazine;
N-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone		antibacterial agent;
antimicrobial agent;
antineoplastic agent
isoxaflutole[no description available]low00(trifluoromethyl)benzenes;
aromatic ketone;
cyclopropanes;
isoxazoles;
sulfone		agrochemical;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
proherbicide
cyproconazole[no description available]low00cyclopropanes;
monochlorobenzenes;
tertiary alcohol;
triazoles
cyprodinil[no description available]low00aminopyrimidine;
anilinopyrimidine fungicide;
cyclopropanes;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
irgarol 1051[no description available]low00aryl sulfide;
cyclopropanes;
diamino-1,3,5-triazine		antifouling biocide;
environmental contaminant;
xenobiotic
coprine[no description available]low00cyclopropanes;
dicarboxylic acid monoamide;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite;
mycotoxin
chrysanthemol[no description available]low00cyclopropanes;
homoallylic alcohol;
monoterpenoid;
primary alcohol
cyclopropanol[no description available]low00aliphatic alcohol;
cyclopropanes
garenoxacin[no description available]low00aromatic ether;
cyclopropanes;
isoindoles;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic		antibacterial drug;
non-steroidal anti-inflammatory drug
oxociprofloxacin[no description available]low00cyclopropanes;
N-arylpiperazine;
piperazinone;
quinolinemonocarboxylic acid;
quinolone		drug metabolite
bay-s 9435[no description available]low00cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
organosulfonic acid;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		drug metabolite;
human urinary metabolite
moxifloxacin[no description available]low00aromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug
firocoxib[no description available]low00butenolide;
cyclopropanes;
enol ether;
sulfone		antineoplastic agent;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
iclaprim[no description available]low00aminopyrimidine;
chromenes;
cyclopropanes
roflumilast[no description available]low00aromatic ether;
benzamides;
chloropyridine;
cyclopropanes;
organofluorine compound		anti-asthmatic drug;
phosphodiesterase IV inhibitor
12-hydroxynevirapine[no description available]low00aromatic primary alcohol;
cyclopropanes;
dipyridodiazepine		drug metabolite
transfluthrin[no description available]low00carboxylic ester;
cyclopropanes;
organochlorine compound;
organofluorine compound		pyrethroid ester insecticide
telaprevir[no description available]low00cyclopentapyrrole;
cyclopropanes;
oligopeptide;
pyrazines		antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
pitavastatin[no description available]low00cyclopropanes;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
quinolines;
statin (synthetic)		antioxidant
calcipotriene[no description available]low00cyclopropanes;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
triol		antipsoriatic;
drug allergen
ro 42-5892[no description available]low00cyclopropanes;
diol;
L-histidine derivative;
secondary carboxamide;
sulfone		antihypertensive agent;
EC 3.4.23.15 (renin) inhibitor;
peptidomimetic;
vasodilator agent
bifenthrin[no description available]low00carboxylic ester;
cyclopropanecarboxylate ester;
cyclopropanes;
organochlorine compound;
organofluorine compound		pyrethroid ester acaricide;
pyrethroid ester insecticide
prothioconazole[no description available]low00cyclopropanes;
monochlorobenzenes;
tertiary alcohol;
thiocarbonyl compound;
triazoles
prasugrel[no description available]low00acetate ester;
cyclopropanes;
ketone;
monofluorobenzenes;
tertiary amino compound;
thienopyridine
lenvatinib[no description available]low00aromatic amide;
aromatic ether;
cyclopropanes;
monocarboxylic acid amide;
monochlorobenzenes;
phenylureas;
quinolines		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist;
orphan drug;
vascular endothelial growth factor receptor antagonist
finafloxacin[no description available]low00cyclopropanes;
monocarboxylic acid;
nitrile;
organofluorine compound;
quinolone;
secondary amino compound;
tertiary amino compound		antibacterial drug;
antimicrobial agent
n-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxamide[no description available]low00aromatic amide;
cyclopropanes;
organofluorine compound;
pyrazoles;
ring assembly
trametinib[no description available]low00acetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly		anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
bay 60-6583[no description available]low00aminopyridine;
aromatic ether;
aryl sulfide;
cyanopyridine;
cyclopropanes;
monocarboxylic acid amide		adenosine A2B receptor agonist;
anti-inflammatory agent;
cardioprotective agent
narlaprevir[no description available]low00azabicyclohexane;
cyclopropanes;
pyrrolidinecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide;
ureas		anticoronaviral agent;
antiviral drug;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
hepatitis C protease inhibitor
alpha(-(cyclopropylcarbonyl)-2-(methyvlsulfonyl)-beta-oxo-4-(trifluromethyl)benzenepropanenitrile)[no description available]low00(trifluoromethyl)benzenes;
aromatic ketone;
beta-diketone;
cyclopropanes;
nitrile;
sulfone		agrochemical;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
herbicide
lumacaftor[no description available]low00aromatic amide;
benzodioxoles;
benzoic acids;
cyclopropanes;
organofluorine compound;
pyridines		CFTR potentiator;
orphan drug
aminocyclopyrachlor[no description available]low00cyclopropanes;
organochlorine pesticide;
pyrimidines		herbicide;
synthetic auxin
olaparib[no description available]low00cyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines		antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
mk-7009[no description available]low00azamacrocycle;
carbamate ester;
cyclopropanes;
N-sulfonylcarboxamide;
pyrrolidinecarboxamide		antiviral drug;
hepatitis C protease inhibitor
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide[no description available]low00benzamides;
biphenyls;
cyclopropanes;
dicarboxylic acid diamide		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
lucitanib[no description available]low00aromatic ether;
cyclopropanes;
naphthalenecarboxamide;
primary amino compound;
quinolines		antineoplastic agent;
fibroblast growth factor receptor antagonist;
vascular endothelial growth factor receptor antagonist
grazoprevir[no description available]low00aromatic ether;
azamacrocycle;
carbamate ester;
cyclopropanes;
lactam;
N-sulfonylcarboxamide;
quinoxaline derivative		antiviral drug;
hepatitis C protease inhibitor;
hepatoprotective agent
lesinurad[no description available]low00aryl sulfide;
cyclopropanes;
monocarboxylic acid;
naphthalenes;
organobromine compound;
triazoles		uricosuric drug
gsk2879552[no description available]low00benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
MLI-2[no description available]low00aromatic ether;
cyclopropanes;
indazoles;
morpholines;
pyrimidines;
tertiary amino compound		EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
ConditionIndicatedRelationship StrengthStudiesTrials
A-V Dissociation0low10
Abdominal Injuries0low10
Abnormalities, Congenital0low20
Abnormality, Heart0low30
Absence Seizure0low10
Absence Seizures0low10
Acid Aspiration Syndrome0low10
Acidosis0low30
Acidosis, Respiratory0low20
Acute Hypercapnic Respiratory Failure0low20
Acute Hypoxemic Respiratory Failure0low20
Acute Liver Injury, Drug-Induced0low70
Affective Psychosis, Bipolar0low10
Aging0low10
Alcoholic Intoxication0low10
Alkalosis0low10
Allergic Bronchopulmonary Mycosis0low10
Amnesia0low10
Amnesia-Memory Loss0low10
Amnesia, Dissociative0low10
Amnesia, Global0low10
Amnesia, Hysterical0low10
Amnesia, Tactile0low10
Amnesia, Temporary0low10
Amnestic State0low10
Anesthesia0low1900
Anoxemia0low30
Anoxia0low30
Anoxia, Brain0low10
Anoxia, Cerebral0low10
Anoxic Brain Damage0low10
Anoxic Encephalopathy0low10
Anterior Circulation Transient Ischemic Attack0low10
Anti-MuSK Myasthenia Gravis0low10
Anxiety0low30
Apnea0low10
Appendicitis0low10
Arrhythmia0low420
Arrhythmias, Cardiac0low420
Arrythmia0low420
Arterial Diseases, Carotid0low10
Arterial Diseases, Common Carotid0low10
Arterial Diseases, External Carotid0low10
Arterial Diseases, Internal Carotid0low10
Arteriosclerosis0low10
Asphyxia0low20
Asphyxia Neonatorum0low20
Aspiration Pneumonia0low10
Asystole0low20
Atelectasis0low10
Atelectasis, Congestive0low10
Atherosclerotic Disease, Carotid0low10
Atonic Absence Seizure0low10
Atonic Absence Seizures0low10
Atonic Seizure0low10
Atonic Seizures0low10
Atrial Flutter0low10
Atrioventricular Dissociation0low10
Atrioventricular Nodal Re-Entrant Tachycardia0low20
Atrioventricular Reentrant Tachycardia0low20
Auricular Flutter0low10
Auriculo-Ventricular Dissociation0low10
Basal Ganglia Diseases0low10
Basal Ganglia Disorders0low10
Basilar Steal Syndrome0low10
Behavior Disorders0low30
Benign Neoplasms0low20
Bipolar Disorder0low10
Bipolar Mood Disorder0low10
Birth Defects0low20
Blast Injuries0low10
Bleeding0low50
Blood Clot0low10
Blood Coagulation Disorders0low20
Blood Loss, Surgical0low10
Blood Pressure, High0low20
Blood Pressure, Low0low30
Body Weight0low30
Brachial-Basilar Insufficiency Syndrome0low10
Brain Anoxia0low10
Brain Hypoxia0low10
Brain Ischemia0low10
Brain Stem Ischemia, Transient0low10
Brain Stem Transient Ischemic Attack0low10
Brain TIA0low10
Brain Vascular Disorders0low10
Brainstem Ischemia, Transient0low10
Brainstem Transient Ischemic Attack0low10
Breast Cancer0low10
Breast Carcinoma0low10
Breast Neoplasms0low10
Breast Tumors0low10
Breathlessness0low10
Bronchitis0low10
Brugada ECG Pattern0low60
Brugada Syndrome0low60
Brugada Syndrome 10low60
Brugada Type ECG Pattern0low60
Cancer0low20
Cancer of Breast0low10
Cancer of Mouth0low10
Cancer of Prostate0low10
Cancer of Stomach0low10
Cancer of the Breast0low10
Cancer of the Mouth0low10
Cancer of the Prostate0low10
Cancer of the Stomach0low10
Carbon Monoxide Poisoning0low10
Carcinogenesis0low10
Carcinoma0low10
Carcinoma, Anaplastic0low10
Carcinoma, Spindle-Cell0low10
Carcinoma, Undifferentiated0low10
Carcinomatosis0low10
Cardiac Arrest0low20
Cardiac Arrhythmia0low420
Cardiac Arrhythmias0low420
Cardiac Complex, Premature0low10
Cardiac Complexes, Premature0low10
Cardiac Conduction Defect0low60
Cardiac Conduction Defects0low60
Cardiac Conduction System Disease0low60
Cardiac Conduction System Diseases0low60
Cardiac Diseases0low10
Cardiac Disorders0low10
Cardiac Dysrhythmia0low420
Cardiac Failure0low10
Cardiopulmonary Arrest0low20
Cardiovascular Diseases0low20
Carotid Artery Diseases0low10
Carotid Artery Disorders0low10
Carotid Atherosclerosis0low10
Carotid Atherosclerotic Disease0low10
Carotid Circulation Transient Ischemic Attack0low10
Cataract0low10
Cataract, Membranous0low10
Cerebral Anoxia0low10
Cerebral Hypoxia0low10
Cerebral Ischemia0low10
Cerebral Ischemia, Transient0low10
Cerebrovascular Diseases0low10
Cerebrovascular Disorders0low10
Cerebrovascular Insufficiency0low10
Cerebrovascular Occlusion0low10
Chemical and Drug Induced Liver Injury0low70
Chemical Dependence0low10
Chemically-Induced Liver Toxicity0low70
Chronic Disease0low10
Chronic Illness0low10
Chronic Necrotizing Pulmonary Aspergillosis0low10
Chronically Ill0low10
Circulatory Collapse0low50
Circulatory Failure0low50
Clasp-Knife Spasticity0low10
Clonic Seizure0low10
Clonic Seizures0low10
Coagulation Disorders, Blood0low20
Colorectal Cancer0low10
Colorectal Carcinoma0low10
Colorectal Neoplasms0low10
Colorectal Tumors0low10
Common Carotid Artery Diseases0low10
Complex Partial Seizure0low10
Complex Partial Seizures0low10
Complication, Intraoperative0low10
Complication, Peroperative0low10
Complication, Postoperative0low70
Compression Atelectasis0low10
Compression Pulmonary Atelectasis0low10
Congenital Abnormalities0low20
Congenital Defects0low20
Congenital Heart Defect0low30
Congenital Heart Defects0low30
Congenital Heart Disease0low30
Congestive Atelectasis0low10
Congestive Heart Failure0low10
Congestive Pulmonary Atelectasis0low10
Constriction, Pathologic0low10
Constriction, Pathological0low10
Contraction Pulmonary Atelectasis0low10
Convulsion0low10
Convulsion, Non-Epileptic0low10
Convulsions0low10
Convulsive Seizure0low10
Convulsive Seizures0low10
Crescendo Transient Ischemic Attacks0low10
Cyanosis0low10
Death, Sudden0low30
Defects, Congenital0low20
Defects, Congenital Heart0low30
Deficiency, Oxygen0low30
Deformities0low20
Delirium0low10
Delirium of Mixed Origin0low10
Dementia Praecox0low40
Depression0low140
Depression, Bipolar0low10
Depression, Endogenous0low80
Depression, Neurotic0low80
Depression, Unipolar0low80
Depressive Disorder0low80
Depressive Syndrome0low80
Diabetic Glomerulosclerosis0low10
Diabetic Kidney Disease0low10
Diabetic Nephropathies0low10
Diabetic Nephropathy0low10
Diagnosis, Psychiatric0low30
Disease, Pulmonary0low10
Diseases, Pulmonary0low10
Disorders, Blood Coagulation0low20
Drug Abuse0low10
Drug Addiction0low10
Drug Dependence0low10
Drug Habituation0low10
Drug Overdose0low10
Drug Use Disorders0low10
Drug-Induced Acute Liver Injury0low70
Drug-Induced Liver Disease0low70
Drug-Induced Liver Injury0low70
Drunkenness0low10
Ductus Arteriosus, Patent0low10
Dyspnea0low10
Ectopic Heartbeats0low10
Edema-Proteinuria-Hypertension Gestosis0low10
Electrolytes0low10
Emergencies0low30
Emesis0low10
Encephalopathy, Hypoxic0low10
Encephalopathy, Ischemic0low10
EPH Complex0low10
EPH Gestosis0low10
EPH Toxemias0low10
Epileptic Seizure0low10
Epileptic Seizures0low10
Epithelial Neoplasms, Malignant0low10
Epithelial Tumors, Malignant0low10
Epithelioma0low10
Esophagotracheal Fistula0low10
Experimental Lung Inflammation0low20
External Carotid Artery Diseases0low10
Extrapyramidal Disorders0low10
Extrasystole0low10
Extrasystoles0low10
Extravascular Hemolysis0low10
Fallot's Tetralogy0low10
Fetal Anomalies0low20
Fetal Malformations0low20
Focal Neurologic Deficits0low10
Gas Poisoning0low10
Gastric Acid Aspiration Syndrome0low10
Gastric Cancer0low10
Gastric Cancer, Familial Diffuse0low10
Gastric Neoplasms0low10
Gastrointestinal Hemorrhage0low10
Generalized Absence Seizure0low10
Generalized Absence Seizures0low10
Generalized Tonic-Clonic Seizures0low10
Gestosis, EPH0low10
Glomerulosclerosis, Diabetic0low10
Haemolysis0low10
Heart Abnormalities0low30
Heart Arrest0low20
Heart Block0low10
Heart Decompensation0low10
Heart Defect, Congenital0low30
Heart Defects, Congenital0low30
Heart Diseases0low10
Heart Disorders0low10
Heart Failure0low10
Heart Failure, Congestive0low10
Heart Failure, Left-Sided0low10
Heart Failure, Right-Sided0low10
Heart Valve Diseases0low10
Heart Valvular Disease0low10
Heart, Malformation Of0low30
Hematochezia0low10
Hemiplegia0low10
Hemiplegia, Crossed0low10
Hemiplegia, Flaccid0low10
Hemiplegia, Infantile0low10
Hemiplegia, Post-Ictal0low10
Hemiplegia, Spastic0low10
Hemiplegia, Transient0low10
Hemolysis0low10
Hemoperitoneum0low10
Hemorrhage0low50
Hemorrhage, Gastrointestinal0low10
Hemorrhage, Surgical0low10
Hemorrhagic Shock0low30
Hepatitis0low60
Hepatitis A0low10
Hepatitis, Drug-Induced0low70
Hepatitis, Infectious0low10
Hepatitis, Toxic0low70
Hernia, Inguinal0low10
HIV0low10
Human Mammary Carcinoma0low10
Hydronephrosis0low10
Hypercapnia0low10
Hypercapnic Acute Respiratory Failure0low20
Hypercapnic Respiratory Failure0low20
Hypertension0low20
Hypertension-Edema-Proteinuria Gestosis0low10
Hypertension, Pulmonary0low10
Hypospadias0low10
Hypotension0low30
Hypotension, Vascular0low30
Hypothermia0low40
Hypothermia, Accidental0low40
Hypovolemia0low10
Hypovolemic0low10
Hypovolemic Shock0low50
Hypoxemia0low30
Hypoxemic Acute Respiratory Failure0low20
Hypoxemic Respiratory Failure0low20
Hypoxia0low30
Hypoxia, Brain0low10
Hypoxia, Cerebral0low10
Hypoxic Brain Damage0low10
Hypoxic Encephalopathy0low10
Icterus0low10
Idiopathic Ventricular Tachycardia0low20
Illuminating Gas Poisoning0low10
Infant, Newborn, Diseases0low20
Infections, Respiratory0low10
Infections, Respiratory Tract0low10
Infections, Upper Respiratory0low10
Infections, Upper Respiratory Tract0low10
Infectious Hepatitis0low10
Inflammation0low20
Inguinal Hernia0low10
Inguinal Hernia, Direct0low10
Inguinal Hernia, Indirect0low10
Injuries0low30
Injuries and Wounds0low30
Injuries, Abdominal0low10
Injuries, Blast0low10
Injuries, Surgical0low10
Injuries, Wounds0low30
Innate Inflammatory Response0low20
Internal Carotid Artery Diseases0low10
Intoxication, Alcoholic0low10
Intracapillary Glomerulosclerosis0low10
Intracranial Vascular Disorders0low10
Intraoperative Complications0low10
Intravascular Hemolysis0low10
Invasive Pulmonary Aspergillosis0low10
Ischemia, Cerebral0low10
Ischemic Attack, Transient0low10
Ischemic Encephalopathy0low10
Jacksonian Seizure0low10
Jaundice0low10
Jaundice, Hemolytic0low10
Kidney Papillary Necrosis0low10
Kimmelstiel-Wilson Disease0low10
Kimmelstiel-Wilson Syndrome0low10
Koch's Disease0low30
Kochs Disease0low30
Laryngeal Spasm0low10
Laryngismus0low10
Laryngospasm0low10
Left-Sided Heart Failure0low10
Lens Opacities0low10
Lenticulostriate Disorders0low10
Liver Diseases0low50
Liver Dysfunction0low50
Liver Injury, Drug-Induced0low70
Liver Injury, Drug-Induced, Acute0low70
Lobar Pneumonia0low20
Lock Jaw0low10
Lockjaw0low10
Low Blood Pressure0low30
Lung Collapse0low10
Lung Diseases0low10
Lung Inflammation0low20
Malignancy0low20
Malignant Epithelial Neoplasms0low10
Malignant Neoplasm of Breast0low10
Malignant Neoplasms0low20
Malignant Tumor of Breast0low10
Mammary Cancer0low10
Mammary Carcinoma, Human0low10
Mammary Neoplasm, Human0low10
Mammary Neoplasms, Human0low10
Manic Depression0low10
Manic Disorder0low10
Manic-Depressive Psychosis0low10
Manifestations, Neurologic0low10
Manifestations, Neurological0low10
Masseter Muscle Spasm0low10
Masseter Spasm0low10
Melancholia0low80
Mendelson Syndrome0low10
Mendelson's Syndrome0low10
Mental Disorders0low30
Mental Disorders, Severe0low30
Mental Illness0low30
Metabolic Acidosis0low30
Monoplegia0low10
Mouth Cancer0low10
Mouth Neoplasms0low10
Muscle Contraction0low20
Muscle Spasm0low10
Muscle Spasticity0low10
Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis0low10
Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis0low10
Muscular Spasm0low10
MuSK MG0low10
MuSK Myasthenia Gravis0low10
Myasthenia Gravis0low10
Myasthenia Gravis, Generalized0low10
Myasthenia Gravis, Ocular0low10
Mycobacterium tuberculosis Infection0low30
Myocardial Failure0low10
Myoclonic Seizure0low10
Myoclonic Seizures0low10
Narcosis0low10
Nausea0low10
Necrosis0low10
Necrotizing Pyelonephritis0low10
Neonatal Diseases0low20
Neoplasia0low20
Neoplasm0low20
Neoplasms0low20
Neoplasms, Benign0low20
Neoplasms, Breast0low10
Neoplasms, Colorectal0low10
Neoplasms, Gastric0low10
Neoplasms, Malignant Epithelial0low10
Neoplasms, Mouth0low10
Neoplasms, Oral0low10
Neoplasms, Prostate0low10
Neoplasms, Prostatic0low10
Neoplasms, Stomach0low10
Neurologic Deficits0low10
Neurologic Dysfunction0low10
Neurologic Findings0low10
Neurologic Manifestation0low10
Neurologic Manifestations0low10
Neurologic Signs0low10
Neurologic Signs and Symptoms0low10
Neurologic Symptoms0low10
Neurological Manifestations0low10
Neuromuscular Blockade0low10
Neurosis, Depressive0low80
Nodular Glomerulosclerosis0low10
Non-Epileptic Seizure0low10
Non-Epileptic Seizures0low10
Nonepileptic Seizure0low10
Nonepileptic Seizures0low10
Nonsustained Ventricular Tachycardia0low20
Oncogenesis0low10
Oral Cancer0low10
Oral Neoplasms0low10
Organic Mental Disorders, Substance-Induced0low10
Organophosphate Poisoning0low20
Organophosphorus Poisoning0low20
Organothiophosphate Poisoning0low20
Organothiophosphonate Poisoning0low20
Oxygen Deficiency0low30
Palsy0low30
Paralysis0low30
Paroxysmal Supraventricular Tachycardia0low20
Partial Seizure0low10
Partial Seizures0low10
Patency of the Ductus Arteriosus0low10
Patent Ductus Arteriosus0low10
Patent Ductus Arteriosus Familial0low10
Pathologic Constriction0low10
Perforated Appendicitis0low10
Peritonitis0low10
Peroperative Complications0low10
Petit Mal Convulsion0low10
Pheochromocytoma0low10
Pheochromocytoma, Extra-Adrenal0low10
Plegia0low30
Pleurisy0low10
Pleuritis0low10
Pneumonia0low20
Pneumonia, Aspiration0low10
Pneumonia, Lobar0low20
Pneumonitis0low20
Poisoning, Carbon Monoxide0low10
Poisoning, Gas0low10
Poisoning, Illuminating Gas0low10
Polyps0low10
Posterior Circulation Transient Ischemic Attack0low10
Postoperative Complications0low70
Postoperative Pulmonary Atelectasis0low10
Pre-Eclampsia0low10
Preeclampsia0low10
Preeclampsia Eclampsia 10low10
Pregnancy0low190
Pregnancy Toxemias0low10
Premature Beats0low10
Premature Cardiac Complex0low10
Premature Cardiac Complexes0low10
Prescription Drug Abuse0low10
Primary Peritonitis0low10
Prostate Cancer0low10
Prostate Neoplasms0low10
Prostatic Cancer0low10
Prostatic Neoplasms0low10
Proteinuria-Edema-Hypertension Gestosis0low10
Pseudoaphakia0low10
Psychiatric Diagnosis0low30
Psychiatric Diseases0low30
Psychiatric Disorders0low30
Psychiatric Illness0low30
Psychoses0low20
Psychoses, Manic-Depressive0low10
Psychosis0low20
Psychosis, Brief Reactive0low20
Psychosis, Manic-Depressive0low10
Psychotic Disorders0low20
Pulmonary Aspergillosis - Invasive0low10
Pulmonary Atelectasis0low10
Pulmonary Consumption0low30
Pulmonary Disease0low10
Pulmonary Diseases0low10
Pulmonary Hypertension0low10
Pulmonary Inflammation0low20
Pulmonary Phthisis0low30
Pulmonary Tuberculoses0low30
Pulmonary Tuberculosis0low30
Pyelonephritis0low10
Pyelonephritis, Acute Necrotizing0low10
Renal Artery Obstruction0low10
Renal Artery Stenosis0low10
Renal Medullary Necrosis0low10
Renal Papillitis, Necrotizing0low10
Research-Related Injuries0low30
Resorption Atelectasis0low10
Resorption Pulmonary Atelectasis0low10
Respiratory Acidosis0low20
Respiratory Depression0low20
Respiratory Failure0low20
Respiratory Infections0low10
Respiratory Insufficiency0low20
Respiratory Tract Infections0low10
Right Bundle Branch Block, ST Segment Elevation, and Sudden Death Syndrome0low60
Right-Sided Heart Failure0low10
Ruptured Appendicitis0low10
Schizoaffective Disorder0low20
Schizophrenia0low40
Schizophrenic Disorders0low40
Schizophreniform Disorders0low20
Secondary Peritonitis0low10
Seizure0low10
Seizures0low10
Seizures, Auditory0low10
Seizures, Clonic0low10
Seizures, Convulsive0low10
Seizures, Epileptic0low10
Seizures, Focal0low10
Seizures, Generalized0low10
Seizures, Gustatory0low10
Seizures, Motor0low10
Seizures, Olfactory0low10
Seizures, Sensory0low10
Seizures, Somatosensory0low10
Seizures, Tonic0low10
Seizures, Tonic-Clonic0low10
Seizures, Vertiginous0low10
Seizures, Vestibular0low10
Seizures, Visual0low10
Shock0low50
Shock, Hemorrhagic0low30
Shock, Surgical0low10
Shock, Traumatic0low20
Shortness of Breath0low10
Single Seizure0low10
Spasm0low10
Spasm, Ciliary Body0low10
Spasm, Generalized0low10
Spastic0low10
Stenosis0low10
Stomach Cancer0low10
Stomach Neoplasms0low10
Stricture0low10
Stupor0low10
Subacute Delirium0low10
Subclavian Artery Stenosis0low10
Subclavian Steal0low10
Subclavian Steal Phenomenon0low10
Subclavian Steal Syndrome0low10
Subclavian-Carotid Artery Steal Syndrome0low10
Substance Abuse0low10
Substance Addiction0low10
Substance Dependence0low10
Substance Use0low10
Substance Use Disorders0low10
Substance-Related Disorders0low10
Sudden Death0low30
Sudden Unexplained Death Syndrome0low60
Sudden Unexplained Nocturnal Death Syndrome0low60
Sudden Unexplained Nocturnal Death Syndrome (SUNDS)0low60
Suffocation0low20
Suicidal Ideation0low10
Surgical Blood Loss0low10
Surgical Hemorrhage0low10
Surgical Injuries0low10
Surgical Shock0low10
Symptom Cluster0low10
Syndrome0low10
Tachyarrhythmia0low40
Tachycardia0low40
Tachycardia, Ventricular0low20
Tetralogy of Fallot0low10
Tetralogy, Fallot's0low10
Thoracic Diseases0low10
Thromboembolism0low10
Thrombosis0low10
Thrombus0low10
TIA (Transient Ischemic Attack)0low10
Todd Paralysis0low30
Todd's Paralysis0low30
Tonic Clonic Seizure0low10
Tonic Seizure0low10
Tonic Seizures0low10
Tonic-Clonic Seizure0low10
Tonic-Clonic Seizures0low10
Toxemia Of Pregnancy0low10
Toxemias, Pregnancy0low10
Toxic Hepatitis0low70
Tracheoesophageal Fistula0low10
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Trauma0low30
Trismus0low10
Tuberculoses, Pulmonary0low30
Tuberculosis0low30
Tuberculosis, Pulmonary0low30
Tumorigenesis0low10
Tumors0low20
Tumors, Breast0low10
Unipolar Depression0low80
Upper Respiratory Infections0low10
Upper Respiratory Tract Infection0low10
Upper Respiratory Tract Infections0low10
Valvular Heart Diseases0low10
Vascular Diseases, Intracranial0low10
Vascular Hypotension0low30
Ventilatory Depression0low20
Ventricular Fibrillation0low60
Ventricular Tachyarrhythmias0low20
Ventricular Tachycardia0low20
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Vomiting0low10
Wounds0low30
Wounds and Injuries0low30
Wounds and Injury0low30
Wounds, Injury0low30

Research Highlights

Safety/Toxicity (2)

ArticleYear
Enhanced toxicity of 2,2-bis(chloromethyl) trimethylene bis[bis(2-chloroethyl) phosphate] (V6) by nanopolystyrene particles towards HeLa cells.
Nanotoxicology, Volume: 17, Issue: 3		2023
DNA interstrand crosslinking agents: synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD).
Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue: 21		2006
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (1)

ArticleYear
Effects of low concentrations of cyclopropane and halothane on peak velocity of saccadic eye movements.
British journal of anaesthesia, Volume: 67, Issue: 6		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (1)

ArticleYear
Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors.
Journal of medicinal chemistry, Apr-28, Volume: 54, Issue: 8		2011
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (2)

ArticleYear
Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude mice.
Journal of medicinal chemistry, Oct-09, Volume: 46, Issue: 21		2003
Anesthetic potency of dezocine and its interaction with morphine in rats.
Anesthesia and analgesia, Volume: 62, Issue: 10		1983
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]